2008
DOI: 10.4314/wajm.v26i4.28324
|View full text |Cite
|
Sign up to set email alerts
|

Review Article: Ophthalmic manifestations of multiple myeloma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
31
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(32 citation statements)
references
References 0 publications
0
31
0
1
Order By: Relevance
“…3 However, the present clinic case could be the first case described in the literature of uveal effusion associated to MGIS, a benign expression but a potential precursor of multiple myeloma.…”
Section: Discussionmentioning
confidence: 86%
“…3 However, the present clinic case could be the first case described in the literature of uveal effusion associated to MGIS, a benign expression but a potential precursor of multiple myeloma.…”
Section: Discussionmentioning
confidence: 86%
“…The pathophysiology of crystal deposition is still largely unclear, but is thought to be related to increased IgG levels (less commonly, IgA) in the tears, aqueous, and limbal vessels of the eye. This then manifests as crystalline deposits usually in the corneal epithelium or stroma, possibly due to spontaneous crystallization of the protein [2,7,8,9].…”
Section: Discussionmentioning
confidence: 99%
“…ciliary cysts, or immunoglobulin deposition [1,2,3]. More specifically, myeloma can cause crystalline or non-crystalline deposits in the cornea -this finding tends to occur during the late phase of the disease, but may be the initial manifestation of the underlying asymptomatic gammopathy [4,5].…”
mentioning
confidence: 99%
“…The treatments include chemotherapy, radiation, or bone marrow transplantation. Ocular findings may be the first manifestation of MM [298]. It may also occur as one of the extramedullary manifestations of the disease or as the first sign of insufficient chemotherapy.…”
Section: Anticancer Role Of Pparγ Agonists As Adjuvant or Combinatmentioning
confidence: 99%
“…MM causes ocular pathology by direct infiltration or as extramedullary plasmacytomas resulting in the displacement or compression of tissues causing hyperviscosity syndrome and immunoglobulin light chain deposition in ocular tissues. Virtually any ocular structure can be affected, including the conjunctiva, cornea, sclera, lens, retina, optic nerve, lacrimal glands, and orbit [298] (Figure 5). …”
Section: Anticancer Role Of Pparγ Agonists As Adjuvant or Combinatmentioning
confidence: 99%